Oppenheimer & Co. Inc. reduced its stake in abrdn Healthcare Investors (NYSE:HQH - Free Report) by 17.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 143,001 shares of the financial services provider's stock after selling 31,267 shares during the quarter. Oppenheimer & Co. Inc. owned approximately 0.27% of abrdn Healthcare Investors worth $2,322,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in HQH. Millstone Evans Group LLC purchased a new stake in shares of abrdn Healthcare Investors during the 4th quarter worth approximately $29,000. Brown Brothers Harriman & Co. acquired a new position in shares of abrdn Healthcare Investors during the fourth quarter valued at about $48,000. Nexus Investment Management ULC acquired a new stake in shares of abrdn Healthcare Investors during the first quarter worth $64,000. CoreCap Advisors LLC grew its stake in abrdn Healthcare Investors by 175.8% during the 4th quarter. CoreCap Advisors LLC now owns 7,262 shares of the financial services provider's stock valued at $117,000 after purchasing an additional 4,629 shares during the last quarter. Finally, Wealthfront Advisers LLC acquired a new position in shares of abrdn Healthcare Investors in the fourth quarter valued at about $118,000. 32.60% of the stock is currently owned by institutional investors.
abrdn Healthcare Investors Trading Up 0.3%
Shares of abrdn Healthcare Investors stock traded up $0.04 on Monday, reaching $15.57. 225,995 shares of the stock were exchanged, compared to its average volume of 196,560. The business has a 50 day moving average price of $15.61 and a two-hundred day moving average price of $16.29. abrdn Healthcare Investors has a twelve month low of $13.77 and a twelve month high of $19.79.
abrdn Healthcare Investors Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Thursday, May 22nd will be given a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a yield of 13.87%. The ex-dividend date of this dividend is Thursday, May 22nd. This is a positive change from abrdn Healthcare Investors's previous quarterly dividend of $0.50.
About abrdn Healthcare Investors
(
Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Featured Articles
Before you consider abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.
While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
